Nintedanib (Ofev) is recommended as a possible treatment for people with idiopathic pulmonary fibrosis if:
their forced vital capacity (FVC; a test of lung function) is between 50% and 80% of the value expected for them
treatment is stopped if the disease gets worse (that is, if their FVC falls by 10% or more of the value expected for them in 12 months).
If you have idiopathic pulmonary fibrosis, and your doctor thinks that nintedanib is the right treatment, you should be able to have the treatment on the NHS.
Nintedanib should be available on the NHS within 3 months of the guidance being issued.
If you are not eligible for treatment as described above, you should be able to continue taking nintedanib until you and your doctor decide it is the right time to stop.